Thank you.
I would say two things, the one is there isn't a waiver proposal yet on the table but it's also very important to understand how the TRIPS waiver operates.
The TRIPS waiver only allows a WTO member to enact domestic measures so as not to implement various provisions of the TRIPS agreement with regard to COVID-19. In other words, a TRIPS waiver would not, by itself, suspend patents.
The second question with respect to Canada in the domestic context is what exactly would Canada be suspending and what patents does Canada hold that go towards the vaccine production or mRNA production. I'm not aware that there are any in fact.
The waiver itself is waiving us from international obligations, not to implement those obligations domestically.